Combining prostate cancer drugs could delay drug resistance, study finds
Institute of Cancer Research,
Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they…
Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
Overview of attention for article published in Cancer Research, April 2012
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
High Attention Score compared to outputs of the same age and source (96th percentile)
Readers on
- mendeley
- 137 Mendeley